Search
Biospace news
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 21 hours 17 min ago
Flagship-Backed Prologue Launches with $50M to DELVE into Viral Proteome
Flagship-Backed Prologue Launches with $50M to DELVE into Viral Proteome 5/7/2024
Vertex Touts 13% Revenue Jump, Beats Profit Estimates on Strong Cystic Fibrosis Performance
Vertex Touts 13% Revenue Jump, Beats Profit Estimates on Strong Cystic Fibrosis Performance 5/7/2024
AAV Manufacturing Takes Center Stage at ASGCT24
AAV Manufacturing Takes Center Stage at ASGCT24 5/7/2024
ADC Therapeutics Posts Early Phase II Lymphoma Data for Zynlonta as Revenue Drops 5.8%
ADC Therapeutics Posts Early Phase II Lymphoma Data for Zynlonta as Revenue Drops 5.8% 5/7/2024
Preliminary Findings Point to Low Risk of Secondary Cancers from CAR-T Therapies
Preliminary Findings Point to Low Risk of Secondary Cancers from CAR-T Therapies 5/7/2024
FDA Sets Date for Eli Lilly’s Donanemab Adcomm While Pondering Changes to Format
FDA Sets Date for Eli Lilly’s Donanemab Adcomm While Pondering Changes to Format 5/7/2024
FDA Rejects Rocket’s Gene Therapy, Cites Need for Additional CMC Info
FDA Rejects Rocket’s Gene Therapy, Cites Need for Additional CMC Info 6/28/2024
Alumis Pushes Through With Smaller IPO, Looks to Raise $250M for Immuno Candidate
Alumis Pushes Through With Smaller IPO, Looks to Raise $250M for Immuno Candidate 6/28/2024
ICER Doubles Down on Critique of Lykos’ MDMA Therapy, Cites Data Concerns
ICER Doubles Down on Critique of Lykos’ MDMA Therapy, Cites Data Concerns 6/28/2024
FDA Needs to Step Up As Use of Third-Party Manufacturers Leads to Rejections
FDA Needs to Step Up As Use of Third-Party Manufacturers Leads to Rejections 6/28/2024
With Latest Expansion in Ohio, Resilience Can Best Serve Partners and Patients
With Latest Expansion in Ohio, Resilience Can Best Serve Partners and Patients 6/28/2024
Illumina Reports $1.47B ‘Goodwill’ Impairment Charge After Grail Spinoff
Illumina Reports $1.47B ‘Goodwill’ Impairment Charge After Grail Spinoff 6/28/2024
AbbVie Expands Immuno Portfolio With $250M Celsius Buy as Humira Hits Patent Cliff
AbbVie Expands Immuno Portfolio With $250M Celsius Buy as Humira Hits Patent Cliff 6/28/2024
Merck’s ADC Pact With Daiichi Hits Regulatory Setback in FDA Rejection
Merck’s ADC Pact With Daiichi Hits Regulatory Setback in FDA Rejection 6/27/2024
Verona Wins FDA Approval for COPD Drug, Eyes Q3 Launch With $1B Financing for Rollout
Verona Wins FDA Approval for COPD Drug, Eyes Q3 Launch With $1B Financing for Rollout 6/27/2024
Novo Ends Phase III Kidney Disease Trial, Incurs More Than $800M Q2 Impairment Loss
Novo Ends Phase III Kidney Disease Trial, Incurs More Than $800M Q2 Impairment Loss 6/27/2024
AbbVie, Genmab Secure FDA Label Expansion for Epkinly in Follicular Lymphoma
AbbVie, Genmab Secure FDA Label Expansion for Epkinly in Follicular Lymphoma 6/27/2024
CDC Narrows RSV Vaccine Recommendations for Seniors
CDC Narrows RSV Vaccine Recommendations for Seniors 6/27/2024
New Team, Same Company: How to Transition to Your New Role
New Team, Same Company: How to Transition to Your New Role 6/27/2024
Leadership Lab: 3 Strategies for an Executive’s Discreet Job Search
Leadership Lab: 3 Strategies for an Executive’s Discreet Job Search 6/27/2024
World Pharma News
- Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia
- Study shows ancient viruses fuel modern-day cancers
- Darolutamide meets primary endpoint in Phase III ARANOTE trial
- Pfizer advances development of once-daily formulation of oral GLP-1 receptor agonist danuglipron
- New AI approach optimizes antibody drugs